VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
YCBDcbdMD, Inc.
$0.70$7M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
HomeStocksYCBDBalance Sheet

cbdMD, Inc. (YCBD) Balance Sheet

10Y historyFree accessUpdated daily

The company's financial stability appears compromised by an accumulated deficit of $180.6M in retained earnings and a reliance on $2.4M in goodwill, which may be subject to future impairment charges.

YCBD Balance Sheet

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricTTMSep'25Sep'24Sep'23Sep'22Sep'21Sep'20Sep'19Sep'18Sep'17Sep'16
Total Current Assets8.38M6.55M6.39M8.07M16.01M36.5M23.71M15.74M11.79M3.69M956.32K
Cash & Short-Term Investments2.64M2.26M2.45M1.8M7.72M27.44M15.1M5.49M6.49M1.14M34.26K
Cash Only2.64M2.26M2.45M1.8M6.72M26.41M14.82M4.69M4.28M284.25K34.26K
Short-Term Investments00001M1.03M276.47K798.54K2.21M859.11K0
Accounts Receivable1.57M1.04M983.91K1.22M1.45M1.11M911.48K2.67M4.2M1.38M163.97K
Days Sales Outstanding21.4619.818.4318.3814.939.147.9441.143.34K112.4829.46
Inventory3.65M2.95M2.37M4.05M4.26M5.02M4.89M4.3M123.22K588.2K687.47K
Days Inventory Outstanding134.41148.9399.96133.05104.26118.16115.08171.84137.73158.4155.04
Other Current Assets520.11K277.15K406.67K750.38K703.32K1.16M1.39M1.3M589.54K583.15K0
Total Non-Current Assets3.87M3.87M4.19M8.13M24.78M88.38M87.13M78.78M3.23M3.38M667.04K
Property, Plant & Equipment722.68K1.04M602.79K4.07M5.55M8.71M10.83M2.47M53.48K135.48K180.28K
Fixed Asset Turnover20.14x18.38x32.32x5.94x6.38x5.11x3.87x9.58x8.58x33.03x11.27x
Goodwill0000056.67M54.67M54.67M000
Intangible Assets2.38M2.12M2.89M3.22M17.83M23.12M21.64M21.64M3.17M3.24M486.76K
Long-Term Investments2.8M700K700K700K1.4M000000
Other Non-Current Assets62.71K00138.71K1.64B-114.18K000-2.44B0
Total Assets12.25M10.42M10.58M16.2M40.79M124.88M110.84M94.52M15.02M7.07M1.62M
Asset Turnover1.80x1.84x1.84x1.49x0.87x0.36x0.38x0.25x0.03x0.63x1.25x
Asset Growth %-15.95%-1.53%-34.66%-60.3%-67.34%12.67%17.27%529.38%112.43%335.48%-
Total Current Liabilities2.97M3.19M8.62M4.67M5.29M6.92M7.69M3.71M969.96K1.52M1.9M
Accounts Payable1.39M1.17M1.54M1.91M2.04M2.98M2.85M3.02M481.58K465.48K206.16K
Days Payables Outstanding9.65K59.3165.1362.5849.8970.0967.06120.7538.27125.3546.49
Short-Term Debt415.13K778.24M1.17M2.49K9.61K59.47K2.07M000797.55K
Deferred Revenue (Current)490.1M506.29M503.25K185.25K0045.14K7.34K161.46K41.42K0
Other Current Liabilities705.53K-1.28B00002.72M0000
Current Ratio2.82x2.05x0.74x1.73x3.03x5.28x3.08x4.24x12.16x2.42x0.50x
Quick Ratio1.59x1.13x0.47x0.86x2.22x4.55x2.45x3.08x12.03x2.04x0.14x
Cash Conversion Cycle-9.49K109.4253.2688.8469.2957.2155.9692.292.94K145.52138.01
Total Non-Current Liabilities0002.49M4.08M14.82M23.97M53.2M28.5K397K12K
Long-Term Debt000000602.1K00360K0
Capital Lease Obligations201.24K002.4M3.68M4.86M6.01M0000
Deferred Tax Liabilities000000895K2.24M21K37K12K
Other Non-Current Liabilities00090.37K401.49K9.96M16.46M50.96M7.5K00
Total Liabilities2.97M3.19M8.62M7.16M9.37M21.74M31.66M56.91M998.46K1.92M1.92M
Total Debt415.13K778.24M1.27M3.68M4.87M6.07M8.68M194.47K0360K797.55K
Net Debt-2.22M775.98M-1.18M1.89M-1.85M-20.34M-6.14M-4.5M-4.28M75.75K763.29K
Debt / Equity0.04x107.70x0.65x0.41x0.15x0.06x0.11x0.01x-0.07x-
Debt / EBITDA-0.43x----------
Net Debt / EBITDA2.32x----------
Interest Coverage---108.10x---678.05x---1881.75x-0.48x-24.09x
Total Equity9.28M7.23M1.96M9.03M31.42M103.14M79.18M37.6M14.02M5.15M-292.73K
Equity Growth %2069.97%268.04%-78.26%-71.26%-69.53%30.26%110.57%168.23%172.27%1858.96%-
Book Value per Share0.891.800.464.4723.6784.4878.8894.6081.4030.93-3.19
Total Shareholders' Equity9.28M7.23M1.96M9.03M31.42M103.14M79.18M37.6M12.61M4.21M363.43K
Common Stock10.5K8.92K3.94K2.96K60.67K57.78K52.13K27.72K8.12K5.79K3.4K
Retained Earnings-180.64M-179.44M-182.07M-174.36M-147.42M-73.34M-47.39M-59.61M-6.67M-6.26M-4.49M
Treasury Stock00000000000
Accumulated OCI00000000-2.51M00
Minority Interest000000001.41M937.06K-656.15K

Key Metrics

Growth RegimeContracting
ProfitabilityNegative
Balance SheetVulnerable
Cash FlowBurning
Top Statement Risk

Liquidity and insolvency risk

Verified Source

Metrics are mathematically derived from official filings.

SEC 10-K (2026Q2)

Balance Sheet Erosion and Instability

According to recent financial disclosures, YCBD's total assets have contracted from $15.1M in 2024Q1 to $12.3M in 2026Q2, signaling a persistent decline in the company's resource base as it struggles to maintain operational scale within a highly competitive and fragmented hemp-derived wellness market.

The consistent reduction in total assets suggests that the company is failing to replace its asset base as it consumes capital to fund ongoing operations. This downward trajectory in asset value, coupled with stagnant revenue, implies that the business model is currently unable to generate the internal growth necessary to stabilize its financial position.

Precarious Liquidity and Cash Runway

Based on the 2026Q2 balance sheet, YCBD maintains a cash position of $2.6M, which, while providing a current ratio of 2.82, remains insufficient to offset the structural cash burn and the significant uncertainty surrounding future revenue generation in the discretionary wellness sector.

While the current ratio appears superficially healthy, it is heavily influenced by the composition of current assets which may include slow-moving inventory. Investors should monitor whether this liquidity buffer is sufficient to cover upcoming operational obligations, as the company's history of negative cash flow suggests that this cash runway may be shorter than the headline ratio implies.

Equity Degradation and Accumulated Deficits

As reported in recent filings, YCBD's retained earnings have plummeted to a deficit of $180.6M as of 2026Q2, reflecting years of value-destructive capital allocation and the persistent inability of the core business to achieve sustained profitability despite its premium brand positioning.

The massive accumulated deficit indicates that the company has consistently failed to generate returns on invested capital, effectively eroding shareholder equity over time. This trend suggests that the current equity base is largely a function of historical financing rather than retained value, leaving little margin for error in future strategic execution.

Hidden Risks in Asset Valuation

Data from the latest balance sheet indicates that goodwill remains at $2.4M, a figure that warrants further investigation given the company's declining revenue and the potential for future impairment charges if the Paw CBD and cbdMD brands fail to meet long-term performance expectations.

The presence of significant goodwill on a shrinking balance sheet suggests that the carrying value of past acquisitions may be overstated relative to current market realities. If management is forced to write down these intangible assets, it would further weaken an already strained equity position and potentially trigger restrictive covenants on existing debt.

YCBD — Frequently Asked Questions

Quick answers to the most common questions about buying YCBD stock.

What are the total assets of cbdMD, Inc. (YCBD)?

As of 2025, cbdMD, Inc. (YCBD) had total assets of $10.4M including $6.6M in current assets.

How much debt does cbdMD, Inc. (YCBD) have?

cbdMD, Inc. (YCBD) carries total debt of $778.2M, offset by $2.3M in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.

What is the book value or shareholders' equity of cbdMD, Inc.?

cbdMD, Inc. (YCBD) has total shareholders' equity (book value) of $7.2M ($1.80 book value per share). Book value represents the net worth of the company belonging to common stock holders.

What is cbdMD, Inc.'s current ratio and liquidity?

cbdMD, Inc. (YCBD) reported a current ratio of 2.05x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.